Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling

被引:26
作者
Bridges, John F. P. [1 ]
Beusterien, Kathleen [2 ]
Heres, Stephan [3 ]
Such, Pedro [4 ]
Sanchez-Covisa, Joaquin [5 ]
Nylander, Anna-Greta [4 ]
Chan, Elcie [6 ]
de Jong-Laird, Anne [5 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[2] Outcomes Res Strategies Hlth, Albemarle St NW, Washington, DC 20008 USA
[3] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[4] H Lundbeck A S, Global Med Affairs, Valby, Denmark
[5] Otsuka Pharmaceut Europe Ltd, Med Dept, Wexham, England
[6] Otsuka Pharmaceut Europe Ltd, HEOR Market Access, Wexham, England
来源
PATIENT PREFERENCE AND ADHERENCE | 2018年 / 12卷
关键词
recent-onset schizophrenia; preferences; treatment goals; PREFERENCES; BURDEN; ONSET; ANTIPSYCHOTICS; DISORDERS; BRAIN; AGE;
D O I
10.2147/PPA.S152870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study seeks to quantify the treatment goals of people recently diagnosed with schizophrenia and explore their impact on treatment plan. Methods: People aged 18-35 years with a confirmed diagnosis of schizophrenia within the past 5 years were surveyed in the UK, Germany, and Italy. Treatment goals were assessed via a validated best-worst scaling instrument, where participants evaluated subsets of 13 possible treatment goals identified using a balanced incomplete block design. Participants identified the most and least important goals within each task. Data were also collected on current treatment and preference for daily oral versus long-acting injectable (LAI) treatment. Hierarchical Bayes was used to identify preference weights for the goals, and latent class analysis was used to identify segments of people with similar goals. The segments were compared with the current treatment and preference for oral versus LAI treatment. Results: Across 100 participants, the average age was 26 years, 75% were male and 50% were diagnosed within 2 years ago. Overall, preferences were most favorable for reduced disease symptoms, think clearly, reduced hospitalizations, reduced anxiety, and take care of self. A total of 61% preferred oral medication and 39% LAI. Two groups were identified with different treatment goals; 50% of participants emphasized clinical goals, including reduced disease symptoms (preference weight = 19.7%), reduced hospitalizations (15.5%), and reduced anxiety (10.5%). The other 50% emphasized functional goals, including improved relationships with family/friends (11.4%), increased interest in work (10.6%), experiencing a fuller range of emotions (8.4%), and ability to socialize (7.5%). Those emphasizing functional goals were more likely to be on LAI (44% versus 26%; p=0.059) and preferred LAI (46% versus 32%; p=0.151). Conclusions: People with recent-onset schizophrenia may focus more on clinical goals or functional goals, a discussion of which may help facilitate patient engagement.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 50 条
  • [1] Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best-Worst Scaling Results
    Bridges, John F. P.
    Goldberg, Joseph F.
    Fitzgerald, Heather M.
    Chumki, Sanjeda R.
    Beusterien, Kathleen
    Will, Oliver
    Citrome, Leslie
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2545 - 2555
  • [2] Prioritizing the worries of AML patients: Quantifying patient experience using best-worst scaling
    Richardson, Daniel R.
    Oakes, Allison H.
    Crossnohere, Norah L.
    Rathsmill, Gary
    Reinhart, Crystal
    O'Donoghue, Bernadette
    Bridges, John F. P.
    PSYCHO-ONCOLOGY, 2021, 30 (07) : 1104 - 1111
  • [3] Perceptions of " sustainable fisheries" " in the UK and Japan using best-worst scaling
    Okazaki, Ryotaro
    Glenk, Klaus
    Makino, Mitsutaku
    MARINE POLICY, 2024, 170
  • [4] Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling
    Peay, Holly Landrum
    Hollin, I. L.
    Bridges, J. F. P.
    JOURNAL OF GENETIC COUNSELING, 2016, 25 (02) : 305 - 313
  • [5] USING BEST-WORST SCALING IN HORIZON SCANNING FOR HEPATOCELLULAR CARCINOMA TECHNOLOGIES
    Gallego, Gisselle
    Bridges, John F. P.
    Flynn, Terry
    Blauvelt, Barri M.
    Niessen, Louis W.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 339 - 346
  • [6] Identifying risk in production agriculture: an application of best-worst scaling
    Atta, Cosmos
    Micheels, Eric T.
    INTERNATIONAL FOOD AND AGRIBUSINESS MANAGEMENT REVIEW, 2020, 23 (02): : 283 - 299
  • [7] Solar cooking in Senegalese villages: An application of best-worst scaling
    Vanschoenwinkel, Janka
    Lizin, Sebastien
    Swinnen, Gilbert
    Azadi, Hossein
    Van Passel, Steven
    ENERGY POLICY, 2014, 67 : 447 - 458
  • [8] Case 2 best-worst scaling: For good or for bad but not for both
    Soekhai, V
    Donkers, B.
    Levitan, B.
    De Bekker-Grob, E. W.
    JOURNAL OF CHOICE MODELLING, 2021, 41
  • [9] R packages and tutorial for case 1 best-worst scaling
    Aizaki, Hideo
    Fogarty, James
    JOURNAL OF CHOICE MODELLING, 2023, 46
  • [10] bwsTools: An R package for case 1 best-worst scaling
    White, Mark H., II
    JOURNAL OF CHOICE MODELLING, 2021, 39